These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30816330)

  • 1. The role of TGFβ in hematopoiesis and myeloid disorders.
    Bataller A; Montalban-Bravo G; Soltysiak KA; Garcia-Manero G
    Leukemia; 2019 May; 33(5):1076-1089. PubMed ID: 30816330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
    Zhou L; McMahon C; Bhagat T; Alencar C; Yu Y; Fazzari M; Sohal D; Heuck C; Gundabolu K; Ng C; Mo Y; Shen W; Wickrema A; Kong G; Friedman E; Sokol L; Mantzaris I; Pellagatti A; Boultwood J; Platanias LC; Steidl U; Yan L; Yingling JM; Lahn MM; List A; Bitzer M; Verma A
    Cancer Res; 2011 Feb; 71(3):955-63. PubMed ID: 21189329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta signaling in normal and malignant hematopoiesis.
    Isufi I; Seetharam M; Zhou L; Sohal D; Opalinska J; Pahanish P; Verma A
    J Interferon Cytokine Res; 2007 Jul; 27(7):543-52. PubMed ID: 17651015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.
    Paracatu LC; Schuettpelz LG
    Front Immunol; 2020; 11():1236. PubMed ID: 32625214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy metabolism and drug response in myeloid leukaemic stem cells.
    Bencomo-Alvarez AE; Rubio AJ; Gonzalez MA; Eiring AM
    Br J Haematol; 2019 Aug; 186(4):524-537. PubMed ID: 31236939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
    Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic
    Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
    Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias.
    Karp JE
    Curr Opin Oncol; 1998 Jan; 10(1):3-9. PubMed ID: 9466478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes.
    Bewersdorf JP; Zeidan AM
    Leukemia; 2019 Jun; 33(6):1303-1312. PubMed ID: 30962581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.
    Ruiz-Gutierrez M; Bölükbaşı ÖV; Alexe G; Kotini AG; Ballotti K; Joyce CE; Russell DW; Stegmaier K; Myers K; Novina CD; Papapetrou EP; Shimamura A
    JCI Insight; 2019 Apr; 5(12):. PubMed ID: 31039138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4.
    Fuchs O; Simakova O; Klener P; Cmejlova J; Zivny J; Zavadil J; Stopka T
    Blood Cells Mol Dis; 2002; 28(2):221-33. PubMed ID: 12064918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
    Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
    Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of hematopoiesis and apoptosis in MDS: more than FLIPing the coin.
    Mhyre AJ; Deeg HJ
    Leuk Res; 2007 Jun; 31(6):747-9. PubMed ID: 17320170
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
    Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
    Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Myelodysplasia a Consequence of Normal Aging?
    Heibl S; Stauder R; Pfeilstöcker M
    Curr Oncol Rep; 2021 Nov; 23(12):142. PubMed ID: 34735656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.